upgrade to Tier 1 to access blurred content, display up to 300 records, and unlimited CSV download
Data last updated 2024-04-28 04:05:40 -0500 US CDT
Insider Sentiment
| Company Name | Sector | Industry | Shares Outstanding(Mil) | 52-week High/Low | Period | Acq/Dsp Transaction Countb | Ids/Sec/Mkt Quantc | Acq/Dsp Shares Amountb | Acq/Dsp PctSOd |
|---|---|---|---|---|---|---|---|---|---|
| Biogen Idec Inc. | Health Care | Biological Products (Diagnostic And Non Diagnostic) | 215.95 |
189.4
319.8
208.9
|
3-month |
0 / 0
|
|
0 / 0
|
0.0 / 0.0 |
| 6-month |
0 / 0
|
|
0 / 0
|
0.0 / 0.0 |
Data last updated 2024-04-27 07:55:23 -0500 US CDT
Major Shareholders
| Shareholder | Relation | Report Date | Holding Pct | Sharesa | Shares(Previous Report Date)a | Transactions (3 month)b | Transactions (6 month)b |
|---|---|---|---|---|---|---|---|
| Denner Alexander J | Director | 2016-06-09 | 0.1% | 318950 (0.3%, NA%) | 317890 (2015-10-26) | ||
| Scangos George A | CEO | 2016-07-22 | 0.0% | 65535 (-0.1%, NA%) | 65692 (2016-06-06) | ||
| Cox John | EVP Pharmaceutical Oper & Tech | 2016-04-05 | 0.0% | 39045 (27.9%, NA%) | 30516 (2016-02-25) | ||
| Alexander Susan H | EVP, Chief Legal Officer | 2017-03-02 | 0.0% | 34990 (9.9%, NA%) | 31840 (2016-02-25) | ||
| Papadopoulos Stelios | Director | 2016-06-09 | 0.0% | 28170 (6.0%, NA%) | 26580 (2015-07-27) | ||
| Clancy Paul J | Executive VP and CFO | 2017-03-14 | 0.0% | 20705 (-32.2%, NA%) | 30596 (2017-03-02) | ||
| Young William | Director | 2014-01-09 | 0.0% | 18509 (NA%, NA%) | () | ||
| Dorsa Caroline | Director | 2016-09-26 | 0.0% | 17093 (0.0%, NA%) | 17093 (2016-06-09) | ||
| Pangia Robert W | Director | 2017-01-10 | 0.0% | 16628 (0.0%, NA%) | 16628 (2016-06-09) | ||
| Rowinsky Eric K | Director | 2016-06-09 | 0.0% | 13065 (8.8%, NA%) | 12005 (2015-06-11) |
C: 1 / 0
S: 455 / 0 P: 222.54 / NA |
C: 1 / 0
S: 455 / 0 P: 222.54 / NA |
a Total of direct and indirect accounts with percentage change comparing with (previous report, 3 months ago). The latter is NA when no change was found in the last 3 months.
Notice: Shares amount and percentage change 1) do not reflect intraday conversion and execution of derivative securities. 2) may subject to correction on amendment filing.
b Vital&Spontaneous transactions of the past 3 and 6 months, respectively. For acquisitions, code P (open market purchase), L (small acquisition), and I (at discretion of broker) are counted. For dispositions, code S (open market sell), D (sell back to issuer) and I (at discretion of broker) are counted. "C:" count of number of transactions. "S:" shares amount involved in corrresponding transactions. "P:" average per share price of the transactions (for reference only). Horizontal bar chart denotes shares amount of acquisitions and dispositions. Black thin bar is fixed size ruler for easy comparison between reporters.
c Quantile value of transaction count in b among industry peers, sector peers, and the market, respectively.
d Percentage of transaction shares amount to shares outstanding.
Notice: red exclamation mark (!) represents the reporter has Form 4 amendment filings in the latest three reports.
Non-derivative Transactions Chart
Tips: Click legend to show single series Click any bar to highlight corresponding transaction records
what is this?
Non-derivative Transactions Table
CSV download
Tips: Click legend to show single series Click any bar to highlight corresponding transaction records what is this?
|
|
|
Tips: type "code_p" to show transactions with code "P".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-04-03 | 2024-04-02 | 2024-04-02 | 4 | Singhal Priya | HEAD OF DEVELOPMENT | dsp | 93.0 | 1.87 | 0.01 | 213.09 | Direct | Common Stock | BIOGEN INC. | code S | 4886.4761 | 145.36 (BIIB) |
| 2024-04-03 | 2024-04-01 | 2024-04-01 | 4 | Murphy Nicole | HEAD OF PHARM OPS AND TECH | dsp | 117.0 | 1.2 | 0.01 | 214.83 | Direct | Common Stock | BIOGEN INC. | code F | 9634.3741 | 145.36 (BIIB) |
| 2024-04-03 | 2024-04-01 | 2024-04-01 | 4 | Murphy Nicole | HEAD OF PHARM OPS AND TECH | acq | 240.0 | 2.46 | 0.02 | 0.0 | Direct | Common Stock | BIOGEN INC. | code M | 9751.3741 | 145.36 (BIIB) |
| 2024-02-26 | 2024-02-22 | 2024-02-22 | 4 | Singhal Priya | HEAD OF DEVELOPMENT | dsp | 262.0 | 5.09 | 0.02 | 221.23 | Direct | Common Stock | BIOGEN INC. | code S | 4886.0915 | 145.36 (BIIB) |
| 2024-02-21 | 2024-02-16 | 2024-02-16 | 4 | Alexander Susan H | EVP CHIEF LEGAL OFFICER | dsp | 2437.0 | 4.5 | 0.17 | 219.08 | Direct | Common Stock | BIOGEN INC. | code F | 51683.0
|
145.36 (BIIB) |
| 2024-02-21 | 2024-02-16 | 2024-02-16 | 4 | Alexander Susan H | EVP CHIEF LEGAL OFFICER | acq | 5037.0 | 9.6 | 0.35 | 0.0 | Direct | Common Stock | BIOGEN INC. | code M | 52464.0
|
145.36 (BIIB) |
| 2024-02-21 | 2024-02-16 | 2024-02-16 | 4 | Kramer Robin | CHIEF ACCOUNTING OFFICER | dsp | 396.0 | 5.98 | 0.03 | 219.08 | Direct | Common Stock | BIOGEN INC. | code F | 6226.7483
|
145.36 (BIIB) |
| 2024-02-21 | 2024-02-16 | 2024-02-16 | 4 | Kramer Robin | CHIEF ACCOUNTING OFFICER | acq | 1345.0 | 21.17 | 0.09 | 0.0 | Direct | Common Stock | BIOGEN INC. | code M | 6353.7483
|
145.36 (BIIB) |
| 2024-02-21 | 2024-02-16 | 2024-02-16 | 4 | Mcdonnell Michael R | EVP, CHIEF FINANCIAL OFFICER | acq | 6720.0 | 32.77 | 0.46 | 0.0 | Direct | Common Stock | BIOGEN INC. | code M | 20507.0
|
145.36 (BIIB) |
| 2024-02-21 | 2024-02-16 | 2024-02-16 | 4 | Mcdonnell Michael R | EVP, CHIEF FINANCIAL OFFICER | dsp | 3438.0 | 15.05 | 0.24 | 219.08 | Direct | Common Stock | BIOGEN INC. | code F | 19406.0
|
145.36 (BIIB) |
| 2024-02-21 | 2024-02-16 | 2024-02-16 | 4 | Murphy Nicole | HEAD OF PHARM OPS AND TECH | dsp | 610.0 | 6.08 | 0.04 | 219.08 | Direct | Common Stock | BIOGEN INC. | code F | 9417.9895
|
145.36 (BIIB) |
| 2024-02-21 | 2024-02-16 | 2024-02-16 | 4 | Murphy Nicole | HEAD OF PHARM OPS AND TECH | acq | 1260.0 | 13.11 | 0.09 | 0.0 | Direct | Common Stock | BIOGEN INC. | code M | 9613.9895
|
145.36 (BIIB) |
| 2024-02-21 | 2024-02-16 | 2024-02-16 | 4 | Singhal Priya | HEAD OF DEVELOPMENT | acq | 1208.0 | 22.25 | 0.08 | 0.0 | Direct | Common Stock | BIOGEN INC. | code M | 5429.0915
|
145.36 (BIIB) |
| 2024-02-21 | 2024-02-16 | 2024-02-16 | 4 | Singhal Priya | HEAD OF DEVELOPMENT | dsp | 576.0 | 10.06 | 0.04 | 219.53 | Direct | Common Stock | BIOGEN INC. | code F S | 5148.0915
|
145.36 (BIIB) |
| 2024-02-21 | 2024-02-16 | 2024-02-16 | 4 | Gregory Ginger | EVP, HUMAN RESOURCES | acq | 4704.0 | 32.87 | 0.32 | 0.0 | Direct | Common Stock | BIOGEN INC. | code M | 14312.716
|
145.36 (BIIB) |
| 2024-02-21 | 2024-02-16 | 2024-02-16 | 4 | Gregory Ginger | EVP, HUMAN RESOURCES | dsp | 2264.0 | 14.29 | 0.16 | 219.08 | Direct | Common Stock | BIOGEN INC. | code F | 13583.716
|
145.36 (BIIB) |
| 2024-02-21 | 2024-02-16 | 2024-02-16 | 4 | Izzar Rachid | HEAD OF GLOBAL PRODUCT STRAT. | dsp | 952.0 | 8.94 | 0.07 | 219.08 | Direct | Common Stock | BIOGEN INC. | code F | 9701.0
|
145.36 (BIIB) |
| 2024-02-21 | 2024-02-16 | 2024-02-16 | 4 | Izzar Rachid | HEAD OF GLOBAL PRODUCT STRAT. | acq | 2017.0 | 20.14 | 0.14 | 0.0 | Direct | Common Stock | BIOGEN INC. | code M | 10014.0
|
145.36 (BIIB) |
| 2024-02-20 | 2024-02-15 | 2024-02-15 | 4 | Rowinsky Eric K | DIRECTOR | acq | 455.0 | 2.21 | 0.03 | 222.54 | Direct | Common Stock | BIOGEN INC. | code P | 20629.0 | 145.36 (BIIB) |
| 2024-02-13 | 2024-02-09 | 2024-02-09 | 4 | Kramer Robin | CHIEF ACCOUNTING OFFICER | dsp | 245.0 | 4.44 | 0.02 | 240.98 | Direct | Common Stock | BIOGEN INC. | code F | 5277.7483 | 144.9 (BIIB) |
| 2024-02-13 | 2024-02-09 | 2024-02-09 | 4 | Kramer Robin | CHIEF ACCOUNTING OFFICER | acq | 833.0 | 15.08 | 0.06 | 0.0 | Direct | Common Stock | BIOGEN INC. | code M | 5522.7483 | 144.9 (BIIB) |
| 2024-02-13 | 2024-02-09 | 2024-02-09 | 4 | Izzar Rachid | HEAD OF GLOBAL PRODUCT STRAT. | dsp | 445.0 | 4.9 | 0.03 | 240.98 | Direct | Common Stock | BIOGEN INC. | code F | 8636.0 | 144.9 (BIIB) |
| 2024-02-13 | 2024-02-09 | 2024-02-09 | 4 | Izzar Rachid | HEAD OF GLOBAL PRODUCT STRAT. | acq | 1515.0 | 16.68 | 0.1 | 0.0 | Direct | Common Stock | BIOGEN INC. | code M | 9081.0 | 144.9 (BIIB) |
| 2024-02-13 | 2024-02-09 | 2024-02-09 | 4 | Mcdonnell Michael R | EVP, CHIEF FINANCIAL OFFICER | acq | 3257.0 | 18.55 | 0.22 | 0.0 | Direct | Common Stock | BIOGEN INC. | code M | 17555.0 | 144.9 (BIIB) |
| 2024-02-13 | 2024-02-09 | 2024-02-09 | 4 | Mcdonnell Michael R | EVP, CHIEF FINANCIAL OFFICER | dsp | 1431.0 | 8.15 | 0.1 | 240.98 | Direct | Common Stock | BIOGEN INC. | code F | 16124.0 | 144.9 (BIIB) |
| 2024-02-13 | 2024-02-09 | 2024-02-09 | 4 | Alexander Susan H | EVP CHIEF LEGAL OFFICER | dsp | 938.0 | 1.88 | 0.06 | 240.98 | Direct | Common Stock | BIOGEN INC. | code F | 49083.0 | 144.9 (BIIB) |
| 2024-02-13 | 2024-02-09 | 2024-02-09 | 4 | Alexander Susan H | EVP CHIEF LEGAL OFFICER | acq | 2575.0 | 5.15 | 0.18 | 0.0 | Direct | Common Stock | BIOGEN INC. | code M | 50021.0 | 144.9 (BIIB) |
| 2024-02-13 | 2024-02-09 | 2024-02-09 | 4 | Singhal Priya | HEAD OF DEVELOPMENT | acq | 1212.0 | 22.83 | 0.08 | 0.0 | Direct | Common Stock | BIOGEN INC. | code M | 5309.0915 | 144.9 (BIIB) |
| 2024-02-13 | 2024-02-09 | 2024-02-09 to 2024-02-12 | 4 | Singhal Priya | HEAD OF DEVELOPMENT | dsp | 793.0 | 14.94 | 0.05 | 240.17 | Direct | Common Stock | BIOGEN INC. | code F S | 4516.0915
|
144.9 (BIIB) |
| 2024-02-13 | 2024-02-09 | 2024-02-09 | 4 | Murphy Nicole | HEAD OF PHARM OPS AND TECH | dsp | 761.0 | 7.99 | 0.05 | 240.98 | Direct | Common Stock | BIOGEN INC. | code F | 8767.9895 | 144.9 (BIIB) |
Derivative Transactions Chart
Tips: Click legend to show single series Click any bar to highlight corresponding transaction records
what is this?
Derivative Transactions Table
Tips: Click legend to show single series Click any bar to highlight corresponding transaction records what is this?
|
|
Tips: type "code_m" to show transactions with code "M".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-04-03 | 2024-04-01 | 2024-04-01 | 4 | Murphy Nicole | HEAD OF PHARM OPS AND TECH | dsp | 240.0 | 100.0 | 0.02 | 0.0 | Direct | Restricted Stock Unit | BIOGEN INC. | code M | 0.0 | 145.36 (BIIB) |
| 2024-02-21 | 2024-02-16 | 2024-02-16 | 4 | Alexander Susan H | EVP CHIEF LEGAL OFFICER | dsp | 3423.0 | 100.0 | 0.24 | 0.0 | Direct | Performance Stock Unit | BIOGEN INC. | code M | 0.0 | 145.36 (BIIB) |
| 2024-02-21 | 2024-02-16 | 2024-02-16 | 4 | Alexander Susan H | EVP CHIEF LEGAL OFFICER | dsp | 3626.0 | 100.0 | 0.25 | 0.0 | Direct | Restricted Stock Unit | BIOGEN INC. | code J M | 0.0
|
145.36 (BIIB) |
| 2024-02-21 | 2024-02-16 | 2024-02-16 | 4 | Kramer Robin | CHIEF ACCOUNTING OFFICER | dsp | 968.0 | 100.0 | 0.07 | 0.0 | Direct | Restricted Stock Unit | BIOGEN INC. | code J M | 0.0
|
145.36 (BIIB) |
| 2024-02-21 | 2024-02-16 | 2024-02-16 | 4 | Kramer Robin | CHIEF ACCOUNTING OFFICER | dsp | 914.0 | 100.0 | 0.06 | 0.0 | Direct | Performance Stock Unit | BIOGEN INC. | code M | 0.0 | 145.36 (BIIB) |
| 2024-02-21 | 2024-02-16 | 2024-02-16 | 4 | Mcdonnell Michael R | EVP, CHIEF FINANCIAL OFFICER | dsp | 4836.0 | 100.0 | 0.33 | 0.0 | Direct | Restricted Stock Unit | BIOGEN INC. | code J M | 0.0
|
145.36 (BIIB) |
| 2024-02-21 | 2024-02-16 | 2024-02-16 | 4 | Mcdonnell Michael R | EVP, CHIEF FINANCIAL OFFICER | dsp | 4568.0 | 100.0 | 0.31 | 0.0 | Direct | Performance Stock Unit | BIOGEN INC. | code M | 0.0 | 145.36 (BIIB) |
| 2024-02-21 | 2024-02-16 | 2024-02-16 | 4 | Murphy Nicole | HEAD OF PHARM OPS AND TECH | dsp | 856.0 | 100.0 | 0.06 | 0.0 | Direct | Performance Stock Unit | BIOGEN INC. | code M | 0.0 | 145.36 (BIIB) |
| 2024-02-21 | 2024-02-16 | 2024-02-16 | 4 | Murphy Nicole | HEAD OF PHARM OPS AND TECH | dsp | 908.0 | 100.0 | 0.06 | 0.0 | Direct | Restricted Stock Unit | BIOGEN INC. | code J M | 0.0
|
145.36 (BIIB) |
| 2024-02-21 | 2024-02-16 | 2024-02-16 | 4 | Singhal Priya | HEAD OF DEVELOPMENT | dsp | 874.0 | 100.0 | 0.06 | 0.0 | Direct | Restricted Stock Unit | BIOGEN INC. | code J M | 0.0
|
145.36 (BIIB) |
| 2024-02-21 | 2024-02-16 | 2024-02-16 | 4 | Singhal Priya | HEAD OF DEVELOPMENT | dsp | 819.0 | 100.0 | 0.06 | 0.0 | Direct | Performance Stock Unit | BIOGEN INC. | code M | 0.0 | 145.36 (BIIB) |
| 2024-02-21 | 2024-02-16 | 2024-02-16 | 4 | Gregory Ginger | EVP, HUMAN RESOURCES | dsp | 3386.0 | 100.0 | 0.23 | 0.0 | Direct | Restricted Stock Unit | BIOGEN INC. | code J M | 0.0
|
145.36 (BIIB) |
| 2024-02-21 | 2024-02-16 | 2024-02-16 | 4 | Gregory Ginger | EVP, HUMAN RESOURCES | dsp | 3197.0 | 100.0 | 0.22 | 0.0 | Direct | Performance Stock Unit | BIOGEN INC. | code M | 0.0 | 145.36 (BIIB) |
| 2024-02-21 | 2024-02-16 | 2024-02-16 | 4 | Izzar Rachid | HEAD OF GLOBAL PRODUCT STRAT. | dsp | 1454.0 | 100.0 | 0.1 | 0.0 | Direct | Restricted Stock Unit | BIOGEN INC. | code J M | 0.0
|
145.36 (BIIB) |
| 2024-02-21 | 2024-02-16 | 2024-02-16 | 4 | Izzar Rachid | HEAD OF GLOBAL PRODUCT STRAT. | dsp | 1370.0 | 100.0 | 0.09 | 0.0 | Direct | Performance Stock Unit | BIOGEN INC. | code M | 0.0 | 145.36 (BIIB) |
| 2024-02-13 | 2024-02-09 | 2024-02-09 | 4 | Kramer Robin | CHIEF ACCOUNTING OFFICER | dsp | 833.0 | 49.97 | 0.06 | 0.0 | Direct | Restricted Stock Unit | BIOGEN INC. | code M | 834.0 | 144.9 (BIIB) |
| 2024-02-13 | 2024-02-09 | 2024-02-09 | 4 | Izzar Rachid | HEAD OF GLOBAL PRODUCT STRAT. | dsp | 1515.0 | 50.0 | 0.1 | 0.0 | Direct | Restricted Stock Unit | BIOGEN INC. | code M | 1515.0 | 144.9 (BIIB) |
| 2024-02-13 | 2024-02-09 | 2024-02-09 | 4 | Mcdonnell Michael R | EVP, CHIEF FINANCIAL OFFICER | dsp | 3257.0 | 50.0 | 0.22 | 0.0 | Direct | Restricted Stock Unit | BIOGEN INC. | code M | 3257.0 | 144.9 (BIIB) |
| 2024-02-13 | 2024-02-09 | 2024-02-09 | 4 | Alexander Susan H | EVP CHIEF LEGAL OFFICER | dsp | 2575.0 | 50.0 | 0.18 | 0.0 | Direct | Restricted Stock Unit | BIOGEN INC. | code M | 2575.0 | 144.9 (BIIB) |
| 2024-02-13 | 2024-02-09 | 2024-02-09 | 4 | Singhal Priya | HEAD OF DEVELOPMENT | dsp | 1212.0 | 50.0 | 0.08 | 0.0 | Direct | Restricted Stock Unit | BIOGEN INC. | code M | 1212.0 | 144.9 (BIIB) |
| 2024-02-13 | 2024-02-09 | 2024-02-09 | 4 | Murphy Nicole | HEAD OF PHARM OPS AND TECH | dsp | 2272.0 | 50.0 | 0.16 | 0.0 | Direct | Restricted Stock Unit | BIOGEN INC. | code M | 2272.0 | 144.9 (BIIB) |
| 2024-02-13 | 2024-02-09 | 2024-02-09 | 4 | Gregory Ginger | EVP, HUMAN RESOURCES | dsp | 2158.0 | 49.99 | 0.15 | 0.0 | Direct | Restricted Stock Unit | BIOGEN INC. | code M | 2159.0 | 144.9 (BIIB) |
| 2024-02-09 | 2024-02-07 | 2024-02-08 | 4 | Alexander Susan H | EVP CHIEF LEGAL OFFICER | dsp | 2190.0 | 33.33 | 0.15 | 0.0 | Direct | Restricted Stock Unit | BIOGEN INC. | code M | 4380.0 | 144.9 (BIIB) |
| 2024-02-09 | 2024-02-07 | 2024-02-07 | 4 | Alexander Susan H | EVP CHIEF LEGAL OFFICER | acq | 5820.0 | 100.0 | 0.4 | 0.0 | Direct | Restricted Stock Unit | BIOGEN INC. | code A | 5820.0 | 144.9 (BIIB) |
| 2024-02-09 | 2024-02-07 | 2024-02-07 | 4 | Gregory Ginger | EVP, HUMAN RESOURCES | acq | 5405.0 | 100.0 | 0.37 | 0.0 | Direct | Restricted Stock Unit | BIOGEN INC. | code A | 5405.0 | 144.9 (BIIB) |
| 2024-02-09 | 2024-02-07 | 2024-02-08 | 4 | Gregory Ginger | EVP, HUMAN RESOURCES | dsp | 1635.0 | 33.33 | 0.11 | 0.0 | Direct | Restricted Stock Unit | BIOGEN INC. | code M | 3270.0 | 144.9 (BIIB) |
| 2024-02-09 | 2024-02-07 | 2024-02-07 | 4 | Singhal Priya | HEAD OF DEVELOPMENT | acq | 6650.0 | 100.0 | 0.46 | 0.0 | Direct | Restricted Stock Unit | BIOGEN INC. | code A | 6650.0 | 144.9 (BIIB) |
| 2024-02-09 | 2024-02-07 | 2024-02-07 | 4 | Viehbacher Christopher | PRESIDENT AND CEO | acq | 27025.0 | 100.0 | 1.87 | 0.0 | Direct | Restricted Stock Unit | BIOGEN INC. | code A | 27025.0 | 144.9 (BIIB) |
| 2024-02-09 | 2024-02-07 | 2024-02-07 | 4 | Grogan Jane | HEAD OF RESEARCH | acq | 4155.0 | 100.0 | 0.29 | 0.0 | Direct | Restricted Stock Unit | BIOGEN INC. | code A | 4155.0 | 144.9 (BIIB) |
| 2024-02-09 | 2024-02-07 | 2024-02-08 | 4 | Izzar Rachid | HEAD OF GLOBAL PRODUCT STRAT. | dsp | 2043.0 | 33.33 | 0.14 | 0.0 | Direct | Restricted Stock Unit | BIOGEN INC. | code M | 4087.0 | 144.9 (BIIB) |
Form 3 CSV download
| Filing Date | Date requiring statement | Form Type | Reporter | Relation | Amounta | ‱(SO)c | Avg Excercisable Prcd | Account | Type | Full Name | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-01-09 | 2024-01-01 | 3 | PATOLAWALA MONISH D | Director | 0.0 | 0.0 | 0.0 | Direct | common stock | BIOGEN INC. | 144.9 (BIIBV) R |
a Sum of same type of securities in the form
b Relative to reporter's shares owned before (disposition) or after (acquisition) operation
c Relative to issuer's shares outstanding (1/10000)
d Average price for securities of the same type. Check the original form for detailed prices of multiple transactions
e Documented shares outstanding closest to the transaction date
Note: Corporate may change mapped CIK when merge or spin-off happen. Please report error if the ticker you searched for does not have up-to-date insider trading information.
Show up to 30 records per table for current tier. (Access Guide)